The Catalytically Active Serine Protease Domain of Human Complement Factor I
- 29 March 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 44 (16) , 6239-6249
- https://doi.org/10.1021/bi047680t
Abstract
Factor I (fI) is a major regulator of complement. As a protease it has very restricted specificity, cleaving only C3b or C4b in the presence of a cofactor such as factor H (fH). Cleavage of C3b by fI yields iC3b, a major opsonin. The cleavage occurs through the formation of a ternary complex between the enzyme, the substrate, and the cofactor. The catalytic subunit of fI, the SP domain, accommodates substrate recognition and cleavage. The role of the fI heavy chain within the catalysis complex is unknown. Using partial proteolysis and affinity chromatography an intact form of the SP domain was generated and isolated from fI in high yield. fI and the SP domain were found to have similar amidolytic activities but strikingly different proteolytic activities on C3(NH3). fI did not cleave C3(NH3) in the absence of fH, while in its presence it cleaved C3(NH3) rapidly at two sites. The SP domain, however, slowly cleaved C3(NH3) in the absence of fH, at more than two sites. Cleavage by the SP domain was inhibited, not stimulated, by fH. Pefabloc SC and antipain inhibited the proteolytic activity of both fI and the SP domain, but suramin inhibited only fI and not the SP domain. The contrast in the proteolytic activities suggests that the heavy chain domains and the cofactor must have roles in orienting the natural substrates and restricting cleavage to the two sites which yield iC3b through a highly specific catalysis.Keywords
This publication has 11 references indexed in Scilit:
- Human Complement Factor I Does Not Require Cofactors for Cleavage of Synthetic SubstratesThe Journal of Immunology, 2004
- Interaction of Kazal-type Inhibitor Domains with Serine Proteinases: Biochemical and Structural StudiesJournal of Molecular Biology, 2002
- Glycosylation and the Complement SystemChemical Reviews, 2002
- The Low Density Lipoprotein Receptor-related Protein Contributes to Selective Uptake of High Density Lipoprotein Cholesteryl Esters by SW872 Liposarcoma Cells and Primary Human AdipocytesJournal of Biological Chemistry, 2001
- Structure and biology of complement protein C3, a connecting link between innate and acquired immunityImmunological Reviews, 2001
- Pharmacological Concentrations of Suramin Inhibit the Binding of α2‐Macroglobulin to its Cell‐Surface ReceptorEuropean Journal of Biochemistry, 1997
- Interactions between human complement components factor H, factor I and C3bBiochemical Journal, 1997
- Inhibition of Neutrophil Serine Proteinases by SuraminPublished by Elsevier ,1997
- [2] ProperdinPublished by Elsevier ,1993
- Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clonesBiochemical Journal, 1987